Media Home
UN Web TV
UN Audiovisual Library
UN PhotoUnifeed
WHO / ZIKA
STORY: WHO / ZIKA
TRT: 1:22
SOURCE: WHO /FILE
RESTRICTIONS: NONE
LANGUAGE: ENGLISH /NATS
DATELINE: 1 FEBRUARY 2017, GENEVA, SWITZERLAND /FILE
FILE
1. Pan right, family with baby with microcephaly at doctor’s
2. Close up, mother with baby with microcephaly
1 FEBRUARY 2017, GENEVA, SWITZERLAND
3. SOUNDBITE (English) Dr Ian Clarke, Zika Incident Manager, WHO:
“In terms of research, a lot of progress has been made since the Declaration of the Public Health Emergency of International Concern, we have done a lot of work around moving forward the vaccine development, we have over 40 candidate vaccines, that we were able to fast-track using the WHO R&D Blueprint, and of course this will take time, potentially another three or four years until those are ready, but good progress has been made around that as well.”
FILE
4. Various shots, doctor exams a baby with microcephaly
1 FEBRUARY 2017, GENEVA, SWITZERLAND
5. SOUNDBITE (English) Dr Ian Clarke, Zika Incident Manager, WHO:
“The importance now is to really help to maintain and coalesce that momentum into a much longer term programme of work. Managing the initial response through an incident management, through an emergency response, was exactly the right thing to do. In the longer term we now need to embed this into the real core programmes of WHO much the way we manage other infectious diseases, chikungunya, yellow fever, dengue.”
FILE
6. Various shots, doctor exams a baby with microcephaly
One year since the declaration the Public Health Emergency of International Concern for Zika virus, the World Health Organization (WHO) said “good progress has been made” in developing a vaccine.
The Public Health Emergency of International Concern (PHEIC) declared by the Director-General of WHO on 1st February 2016 has led the world to an urgent and coordinated response, providing the understanding that Zika virus infection and associated consequences represent a highly significant long-term problem that must be managed by WHO, States Parties and other partners in a way that other infectious disease threats are managed.
Dr Ian Clarke, Zika Incident Manager at the WHO, said “we have done a lot of work around moving forward the vaccine development, we have over 40 candidate vaccines, that we were able to fast-track using the WHO R&D Blueprint, and of course this will take time, potentially another three or four years until those are ready, but good progress has been made around that as well.”
WHO reported 707,000 Zika virus infections from May 2015 to mid December 2016.
The Zika virus is transmitted primarily by the Aedes mosquito. People with Zika virus disease can have symptoms that can include mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache.
Experts are now convinced that Zika virus is a cause of microcephaly as well as Guillain- Barré syndrome.
Download
There is no media available to download.
